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scores”, each clustering a deﬁned set of questions. RESULTS:
(2002 ﬁgures in brackets): Samples did not differ signiﬁcantly in
structure. The 16 practices recruited n = 1639 patients (n =
1826), 50.9% women (55.0); mean age 63.6 years (62.4). Com-
paring 2004 with 2002 it is demonstrated that 5 practices
showed overall improvement in all dimensions, 3 practices
improved in some, 4 practices improved and decreased, while 4
maintained steady state. Patients of one practice reported much
more problems in all dimensions in 2002 than on average. In
2004, the practice presents with only “praxis organisation”
being still an issue for patients (+37%). This practice demon-
strated an overall better performance based on improvements in
8 out of 13 scales. Problem scores dropped (i.e. improvement)
especially interpersonal communication dimensions, i.e. patient-
physician relationship (-56%), co-management (-32%),
involvement of family members (-54%), discussion with other
patients (-41%). CONCLUSION: Assessing patient satisfaction
over time is one tool to generate a platform for quality assur-
ance in oncological care. The PASCOQ® questionnaire is a tool
to assess not only status quo but is also feasible to detect changes
in patients’ satisfaction with physicians, staff, environment as
well as side effects and supportive medication.
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OBJECTIVES: To assess the estimated prevalence of possible
ﬁbromyalgia sufferers among the general adults population in
Portugal using a screening questionnaire, the LFES-SQ developed
by White. METHODS: This questionnaire was administrated to
a random community sample of 500 persons interviewed by tele-
phone and positive responders to the screening questionnaire
were classiﬁed as “pain sufferers”. Using a sample of patients
coming to Rheumatologist departments we administrated to
them the same screening questionnaire and we diagnosed this
entire sample to see if they were ﬁbromyalgia sufferers (using the
1990 ACR criteria). Once we had calculated the ratio between
patients “positive” to the screening questionnaire and the
number of patients really diagnosed with ﬁbromyalgia, we
applied this ratio to our population of “pain sufferers” and
therefore obtain an estimate of the prevalence of possible
ﬁbromyalgia sufferers. It is important to note that we worked 
on two different populations. RESULTS: In Portugal following
the hospital survey the results were the following: 225 inter-
viewed patients (191 women, 34 men) among them 154 were
screened positive (136 and 18) and 51 cases of ﬁbromyalgia (50
and 1) therefore multiplication factors of possible ﬁbromyalgia
patients VS number of positive = Total ﬁbromyalgia cases in
Lisboa / Number of Patients screened positive i.e. . . . multipli-
cation factor for the total population = 51/154 = 0.331; for
women = 50/136 = 0.368 and for men = 1/18 = 0.056. Once
those ratio were applied to our random community representa-
tive sample of 500 persons we obtained the following: an esti-
mated prevalence of FMS in Portugal of 6.09% of the total
population, 8.76% of women and 0.69% of men. CONCLU-
SION: Those data are higher than the ones obtained in the White
study or in the published prevalence of ﬁbromyalgia in the liter-
ature, but they allow us to assess an estimated prevalence of
ﬁbromyalgia.
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OBJECTIVE: To assess the estimated prevalence of possible
Fibromyalgia (FM) sufferers among the general adults popula-
tion in Italy using the LFES-SQ, a screening questionnaire 
developed by White. METHODS: This questionnaire was
administrated to a random community sample of 1000 persons
interviewed by telephone and positive responders to the screen-
ing questionnaire were classiﬁed as “pain sufferers”. Using a
ratio calculated in Portugal between patients “positive” (+) to
the screening questionnaire and the number of patients really
diagnosed with FMS, we applied this ratio to our population of
“pain sufferers” and therefore obtain an estimate of the preva-
lence of possible ﬁbromyalgia sufferers in Italy, please note that
we worked on two different populations. The ratio was calcu-
lated using a sample of patients in Lisboa, to whom we admin-
istrated the same screening questionnaire and we diagnosed this
entire sample to see if they were FMS sufferers (using the 1990
ACR criteria). RESULTS: In Portugal following the hospital
survey we were able to calculate the following ratios: Multipli-
cation factors of possible FMS patients VS number of (+) = Total
FM cases in Lisboa / Number of Patients screened (+), i.e. . . .
multiplication factor for the total population = 51/154 = 0.331;
multiplication factor for women = 50/136 = 0.368; multiplica-
tion factor for men = 1/18 = 0.056. Once those ratio were applied
to our random sample of 1000 persons we obtained an estimated
prevalence of FMS in Italy of 4.17% of the total population,
6.99% of women and 0.31% of men. CONCLUSION: Those
data are higher than those obtained in the White study or in the
published prevalence of FMS in the literature, but they allow us
to assess an estimated prevalence of FMS. The next steps will be
to calculate local multiplication factors of FMS in Italy in order
to improve those estimates and to generalise this survey in
Europe.
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OBJECTIVE: To compare the management of ﬁbromyalgia
amongst French and Portuguese General Practitioners (GPs).
METHODS: A questionnaire with a prepaid envelope was sent
to a sample of 10,000 GPs in France and to all practicing GPs
(n = 8399) in Portugal. This questionnaire was organized in six
main sections: the characteristics of the physician’s professional
practice, the physician’s opinion on ﬁbromyalgia, the main symp-
toms of ﬁbromyalgia, diagnosis criteria, treatments of ﬁbromyal-
gia, sources of knowledge on ﬁbromyalgia. RESULTS: A total of
1130 French GPs (response rate: 11.3%) and 337 Portuguese
GPs (response rate: 4%) returned the questionnaire. In France
66% are male with an average age of 47, whereas in Portugal
52% are male with an average age of 50. The proﬁle of the
respondents is similar in age and gender to the average national
proﬁle. Thirty-three percent of French GPs and 29.5% of the
Portuguese ones afﬁrm that ﬁbromyalgia is a disease; 63% and
68% respectively claim it is a symptom and it is only for 2% of
French and 2.5% of the Portuguese GPs that ﬁbromyalgia does
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not exist (7% of French GPs did not answer). They have an
average of 6.1 and 8.3 patients suffering from ﬁbromyalgia for
the French and Portuguese GPs respectively. Concerning the use
visual analog scales for measurement of pain, if 11% of French
GPs use them systematically and 35% never use them, we have
4% and 44% respectively in Portugal. CONCLUSION: The
comparison between French and Portuguese General Practition-
ers management of FM reveals quite no differences in the pre-
scriptions and for both a low use of morphine like agents.
Concerning other type of management and physical exercises
they essentially differ for acupuncture, osteopathy, hypnotherapy
and bicycling. We can also note important difference concerning
the use of visual analog scales, used more frequently in France.
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OBJECTIVE: To investigate the incremental health care resource
use and costs associated with Fibromyalgia diagnosis.
METHOD: We used data from the UK General Practice
Research Database (GPRD) to study the health care resource use
of patients prior to and following their FM diagnosis. All
patients in GPRD with a diagnosis of Fibromyalgia from
January, 1 1998 and 2-years minimum of data prior to their ﬁrst
diagnosis, were included. Incidence rates of the clinical, therapy,
referral, test and consultation events of interest were estimated
for up to 10-years prior to and up to 4-years after the date of
the diagnosis. A simple cost assessment was performed to
compare the cost of diagnosed patients with Fibromyalgia and
the predicted costs (based on trend analysis) of those patients if
they wouldn’t have been diagnosed. RESULTS: There were 2260
diagnoses of Fibromyalgia. Of these, 81.3% were in females and
mean age was 49-years old. Following the diagnosis of
Fibromyalgia, the visits rate related to depression stabilised and
then declined to 13 per 100 person-years by 4-years post-diag-
nosis. Referral rates declined considerably and the incidence of
tests appeared to stabilise. Rheumatology referrals dropped to
near control levels by 4 years following the Fibromyalgia diag-
nosis. In total, it was estimated that £9082 per 100 patient-years
were saved by making the diagnosis. The major contributor to
this savings was the reduced level of “other referrals” (£5599),
followed by rheumatologists (£1880), GP consultations (£871)
and tests (£621) The reduction in drugs contributed less (£112
per 100 person-years). CONCLUSION: Fibromyalgia is associ-
ated with considerable, long-term morbidity and health care
resource use. A deﬁnitive diagnosis of Fibromyalgia is associated
with a temporary increase in the use of TCAs and SSRIs and with
a reduction in consultations and referrals for associated symp-
toms and in the health care resources and costs used to manage
affected patients.
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OBJECTIVE: To compare the management of ﬁbromyalgia
amongst French and Portuguese Rheumatologists. METHOD: A
questionnaire with a prepaid envelope was sent to all practicing
rheumatologists in France (n = 2614) and Portugal (n = 124).
This questionnaire was organized in six main sections: the char-
acteristics of the physician’s professional practice, the physician’s
opinion on ﬁbromyalgia, the main symptoms of ﬁbromyalgia,
diagnosis criteria, treatments of ﬁbromyalgia, sources of knowl-
edge on ﬁbromyalgia. RESULTS: A total of 430 French and 34
Portuguese rheumatologists (response rate: 17% and 27.4%
respectively) returned the completed questionnaire. In France
66% are male with an average age of 48, whereas in Portugal
61% are male with an average age of 46. The proﬁle of the
respondents is similar in age and gender to the average national
proﬁle. Twenty-three percent of French rheumatologists and
12% of the Portuguese afﬁrm that ﬁbromyalgia is a disease; 72%
and 88% respectively claim it is a symptom and it is only for
2% of French rheumatologists that ﬁbromyalgia does not exist.
They have an average of 30 and 24.5 patients suffering from
ﬁbromyalgia for the French and Portuguese Rheumatologists
respectively. Concerning the use visual analog scales for mea-
surement of pain, if 23% of French Rheumatologists use them
systematically and 18% never use them, we have 12% and 23%
respectively in Portugal. CONCLUSION: The comparison
between French and Portuguese Rheumatologists management
of ﬁbromyalgia reveals some signiﬁcant differences, especially
regarding the prescription of antidepressants more important in
Portugal and the use of visual analog scales is more frequent in
France. Concerning other type of management they essentially
differ for acupuncture and osteopathy, while physical therapies
are very similar.
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OBJECTIVE: To carry out a cross evaluation of the level of
awareness and knowledge of ﬁbromyalgia amongst French and
Portuguese General Practitioners (GPs). METHOD: A question-
naire with a prepaid envelope was sent to a sample of 10,000
GPs in France and to all practicing GPs (n = 8399) in Portugal.
This questionnaire was organized in six main sections: the char-
acteristics of the physician’s professional practice, the physician’s
opinion on ﬁbromyalgia, the main symptoms of ﬁbromyalgia,
diagnosis criteria, treatments of ﬁbromyalgia, sources of knowl-
edge on ﬁbromyalgia. RESULTS: In total, 1130 French GPs and
337 Portuguese GPs (response rate: 11.3% and 4% respectively)
returned the questionnaire. In France 66% are male, average age
of 47, whereas in Portugal 52% are male with an average age of
50. The proﬁle of the respondents is similar in age and gender
to the average national proﬁle. In total, 33% of French GPs and
29.5% of the Portuguese afﬁrm that ﬁbromyalgia is a disease;
63% and 68% respectively claim it is a symptom and it is only
2% of French and 2.5% of the Portuguese GPs that ﬁbromyal-
gia does not exist. They have an average of 6.1 and 8.3 patients
suffering from ﬁbromyalgia for the French and Portuguese GPs
respectively. Concerning the 1990 ACR criteria, if 18% of
French GPs know them completely and 36% partially, we have
33% and 47% respectively in Portugal. CONCLUSION: The
comparison between French and Portuguese General Practition-
